Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Gastric Cancer · Esophagogastric Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    Contact: Study coordinator (Hongda Liu) · Liuhongda@njmu.edu.cn · +86 17521597055
    Hao Xu, MD (Sub-investigator)
    Hongda Liu (Sub-investigator)